11/20
04:05 pm
lung
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
Neutral
Report
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
11/19
09:14 am
lung
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers [Yahoo! Finance]
Medium
Report
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers [Yahoo! Finance]
11/19
09:00 am
lung
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
Low
Report
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
11/7
04:05 pm
lung
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Low
Report
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/5
04:05 pm
lung
Pulmonx to Present at the Stifel 2024 Healthcare Conference
Medium
Report
Pulmonx to Present at the Stifel 2024 Healthcare Conference
11/2
09:53 am
lung
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results [Yahoo! Finance]
High
Report
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results [Yahoo! Finance]
11/1
08:53 am
lung
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
Low
Report
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
10/31
02:35 pm
lung
Pulmonx Co. (NASDAQ: LUNG) had its price target lowered by analysts at Stifel Nicolaus from $17.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Pulmonx Co. (NASDAQ: LUNG) had its price target lowered by analysts at Stifel Nicolaus from $17.00 to $16.00. They now have a "buy" rating on the stock.
10/30
04:05 pm
lung
Pulmonx Reports Third Quarter 2024 Financial Results
Medium
Report
Pulmonx Reports Third Quarter 2024 Financial Results
10/16
04:05 pm
lung
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
Medium
Report
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
9/9
04:05 pm
lung
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
Medium
Report
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
8/29
04:05 pm
lung
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
Neutral
Report
Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
8/22
04:05 pm
lung
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
Medium
Report
Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference